Recursion Pharmaceuticals, Inc.(RXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RXRX Recursion Pharmaceuticals, Inc.

已收盘 10-14 16:00:00 EDT

3.74

-0.09

-2.48%

盘后3.66

-0.08-2.14%

19:59 EDT

最高3.91	最低3.66	成交量1,878万
今开3.72	昨收3.84	日振幅6.52%
总市值20.01亿	流通市值19.53亿	总股本5.35亿
成交额7,046万	换手率3.60%	流通股本5.22亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RXRX","market":"US","secType":"STK","nameCN":"Recursion Pharmaceuticals, Inc.","latestPrice":3.74,"timestamp":1792008000000,"preClose":3.835,"halted":0,"volume":18783664,"hourTrading":{"tag":"盘后","latestPrice":3.66,"preClose":3.74,"latestTime":"19:59 EDT","volume":545735,"amount":2024360.7954,"timestamp":1792022370168,"change":-0.08,"changeRate":-0.02139,"amplitude":0.024064},"delay":0,"changeRate":-0.0247718383311603,"floatShares":522325546,"shares":534999999,"eps":-1.021913,"marketStatus":"已收盘","change":-0.095,"latestTime":"10-14 16:00:00 EDT","open":3.72,"high":3.91,"low":3.66,"amount":70462882.6433392,"amplitude":0.065189,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.021913,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1792051200000},"marketStatusCode":5,"adr":0,"listingDate":1618545600000,"exchange":"NASDAQ","adjPreClose":3.835,"preHourTrading":{"tag":"盘前","latestPrice":3.73,"preClose":3.835,"latestTime":"09:29 EDT","volume":446844,"amount":1697615.317812,"timestamp":1791984599999,"change":-0.105,"changeRate":-0.027379,"amplitude":0.065189},"postHourTrading":{"tag":"盘后","latestPrice":3.66,"preClose":3.74,"latestTime":"19:59 EDT","volume":545735,"amount":2024360.7954,"timestamp":1792022370168,"change":-0.08,"changeRate":-0.02139,"amplitude":0.024064},"volumeRatio":0.623298,"optionData":{"bulkOrders":[{"symbol":"RXRX","call":true,"expireDate":1797570000000,"strike":"4.0","timestamp":1791992512490,"price":0.47,"volume":1990,"amount":93530,"type":"-"}]},"impliedVol":1.0931,"impliedVolPercentile":0.8725},"requestUrl":"/m/hq/s/RXRX/tweets","defaultTab":"tweets","newsList":[{"id":"1124871802","title":"异动解读｜Recursion Pharmaceuticals盘中下跌8.02%，合作协议调整与高管减持引发市场分歧","url":"https://stock-news.laohu8.com/highlight/detail?id=1124871802","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124871802?lang=zh_cn&edition=full","pubTime":"2026-10-12 23:30","pubTimestamp":1791819048,"startTime":"0","endTime":"0","summary":"10月12日，Recursion Pharmaceuticals盘中下跌8.02%，报4.0104美元/股，成交额4772.44万美元。消息面上，公司与Tempus AI的合作协议调整持续引发市场分歧。此外，Tempus AI获得Recursion专有RNA基础模型的全球非独家授权，该协议调整的长期战略价值与短期财务灵活性之间的权衡成为市场博弈焦点。Recursion Pharmaceuticals是一家临床阶段的TechBio公司，通过其递归操作系统整合超过50PB的专有数据，在湿实验室实验与干实验室计算工具之间形成迭代循环，用于识别、验证和转化治疗洞见。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107685757","title":"异动解读｜Recursion Pharmaceuticals盘中上涨8.1%，协议调整与高管减持引发市场分歧","url":"https://stock-news.laohu8.com/highlight/detail?id=1107685757","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107685757?lang=zh_cn&edition=full","pubTime":"2026-10-09 23:52","pubTimestamp":1791561167,"startTime":"0","endTime":"0","summary":"10月9日，Recursion Pharmaceuticals盘中上涨8.1%，报4.27美元/股，成交额6096.86万美元。消息面上，公司与Tempus AI的合作协议调整持续引发市场分歧。Recursion Pharmaceuticals是一家临床阶段的TechBio公司，通过其递归操作系统整合超过50PB的专有数据，在湿实验室实验与干实验室计算工具之间形成迭代循环，用于识别、验证和转化治疗洞见。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Recursion盘中上涨，协议调整引分歧","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172125396","title":"异动解读｜Recursion Pharmaceuticals盘中下跌8.08%，高管减持叠加合作协议调整引发市场分歧","url":"https://stock-news.laohu8.com/highlight/detail?id=1172125396","media":"行情直击","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172125396?lang=zh_cn&edition=full","pubTime":"2026-10-08 22:52","pubTimestamp":1791471169,"startTime":"0","endTime":"0","summary":"10月8日，Recursion Pharmaceuticals盘中下跌8.08%，报3.925美元/股，成交额3770.94万美元。消息面上，公司近期与Tempus AI的合作协议调整引发市场分歧，SEC文件显示Recursion被删除了为便利而单方面终止协议的权利，且未来两年至多8400万美元的自主付款被替换为三年4200万美元的承诺付款，部分投资者担忧公司财务灵活性受限。与此同时，公司近期披露多笔内部人交易，董事Borgeson Blake于10月6日以4.84美元卖出5万股，董事HERSHBERG ROBERT亦卖出2.5万股，高管减持行为进一步压制了市场情绪。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156567702","title":"异动解读｜Recursion Pharmaceuticals盘中下跌8.21%，合作协议调整引发市场分歧","url":"https://stock-news.laohu8.com/highlight/detail?id=1156567702","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156567702?lang=zh_cn&edition=full","pubTime":"2026-10-08 01:30","pubTimestamp":1791394248,"startTime":"0","endTime":"0","summary":"10月8日，Recursion Pharmaceuticals盘中下跌8.21%，报4.245美元/股，成交额1.2亿美元。行业方面，生物科技板块涨跌互现，Moderna上涨1.96%，艾伯维上涨2.53%，而Twist Bioscience下跌5.16%，板块内分化明显。Recursion Pharmaceuticals是一家临床阶段的TechBio公司，通过其递归操作系统整合超过50PB的专有数据，在湿实验室实验与干实验室计算工具之间形成迭代循环，用于识别、验证和转化治疗洞见。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"合作协议生变，Recursion股价大跌","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110777245","title":"Tempus与Recursion续签数据许可协议，并新增Recursion RNA基础模型授权合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1110777245","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110777245?lang=zh_cn&edition=full","pubTime":"2026-09-21 21:15","pubTimestamp":1789996542,"startTime":"0","endTime":"0","summary":"Tempus AI今日宣布，与Recursion Pharmaceuticals, Inc.达成重要合作升级。双方不仅延长了既有的数据许可协议，更在此基础上签署了一项全新的授权协议——聚焦于Recursion研发的RNA基础模型。通过新协议，Tempus将获得Recursion专有的RNA基础模型使用权，此举旨在进一步丰富其多模态数据能力，并强化在精准医疗领域的算法优势。协议的具体财务条款暂未对外披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEMT","BK4611","BK4548","BK4613","ARKG","HEAL","TEMC","LU1861558580.USD","TEM","BK4609","BK4139","BK4539","RXRX","BK4121","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170977867","title":"Recursion Pharmaceuticals 遭删除其单方面终止协议的权利——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1170977867","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170977867?lang=zh_cn&edition=full","pubTime":"2026-09-21 21:13","pubTimestamp":1789996437,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals公司在提交给美国证券交易委员会的文件中显示，该公司已被删除了为便利而单方面终止协议的权利。这一变动意味着，Recursion Pharmaceuticals将不再拥有随时终止协议的选择权，而必须遵循协议中规定的其他终止条款。目前，Recursion Pharmaceuticals尚未对此项变更发表公开评论。随着这一信息的公开，投资者和分析师正在评估其对Recursion Pharmaceuticals长期发展战略及财务状况的潜在影响。SEC文件作为正式的监管披露，其内容的变动通常具有法律效力，因此这一调整值得市场各方深入解读。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4548","BK4611","BK4609","BK4539","RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108711215","title":"Recursion Pharmaceuticals于2026年9月15日与Tempus签署主协议修正案——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1108711215","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108711215?lang=zh_cn&edition=full","pubTime":"2026-09-21 21:07","pubTimestamp":1789996050,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals公司宣布，已于2026年9月15日与Tempus达成一项主协议修正案。这一信息源自其向美国证券交易委员会提交的官方文件。根据SEC文件披露的内容，该协议修订涉及双方此前的合作条款，具体细节则未在此次简短公告中展开详述。Recursion Pharmaceuticals以其在人工智能驱动的药物发现平台方面的工作而闻名，而Tempus则在临床数据与分子信息分析领域占据重要位置。截至目前，公司方面尚未就此次修正案对业务运营或财务前景的具体影响发表进一步评论。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4609","RXRX","BK4139","BK4548","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133649053","title":"Recursion Pharmaceuticals第二季度运营收入730.3万美元，低于IBES预期1190万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1133649053","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133649053?lang=zh_cn&edition=full","pubTime":"2026-08-05 18:45","pubTimestamp":1785926738,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals（RXRX）公布了第二季度财务数据。其运营收入仅为730.3万美元，远低于IBES估算的1190万美元。此外，该公司在报告期内录得税前亏损1.31006亿美元。这一业绩表现与市场预期存在显著差距，反映出公司当前面临的挑战。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4609","BK4611","BK4548","RXRX","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160129009","title":"OpenAI两大更新！推出药物研发模型挑战谷歌，发布Codex可操作电脑持续性工作","url":"https://stock-news.laohu8.com/highlight/detail?id=1160129009","media":"华尔街见闻","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160129009?lang=zh_cn&edition=full","pubTime":"2026-04-17 07:06","pubTimestamp":1776380807,"startTime":"0","endTime":"0","summary":"OpenAI正式进军AI辅助药物研发领域，向谷歌等竞争对手发起挑战，并引发相关上市公司股价大幅下挫。OpenAI还宣布对旗下Codex产品进行更新，新版本支持与用户协同操控电脑，兼容更多常用工具与应用，并可记忆用户偏好、学习历史操作习惯。不过，Joy Jiao同时强调，OpenAI目前并不认为AI可以独立提出新的疾病治疗方案。Codex更新：拓展日常工具协作能力OpenAI发布Codex更新。","market":"us","thumbnail":"https://static.tigerbbs.com/760056d3ed9e8c1a595c0d9f2094cc4d","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/760056d3ed9e8c1a595c0d9f2094cc4d"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3770180","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"OpenAI两大更新！推出药物研发模型挑战谷歌，发布Codex可操作电脑持续性工作","news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1762389672944","symbols":["SDGR","RXRX","CRL","IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518222608","title":"Recursion Pharmaceuticals, Inc.盘中异动 早盘快速下跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518222608?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:33","pubTimestamp":1741613625,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时33分，Recursion Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.08%。截至发稿，该股报6.26美元/股，成交量116.678万股，换手率0.29%，振幅2.43%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2084.06%、406.02%、63.10%，振幅较大的相关个股有Akero Therapeutics, Inc.、Xencor, Inc.、Seer, Inc.，振幅分别为100.05%、99.13%、98.72%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213345a26a2579&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213345a26a2579&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4611","BK4139","BK4539","BK4548","BK4609","RXRX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2516677104","title":"Recursion Pharmaceuticals, Inc.盘中异动 早盘急速跳水5.16%报6.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677104","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516677104?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098737,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Recursion Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.16%。截至发稿，该股报6.25美元/股，成交量282.348万股，换手率0.70%，振幅1.90%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1048.08%、1033.73%、409.49%，振幅较大的相关个股有Adma Biologics Inc、Ocean Biomedical, Inc.、Aditxt, Inc.，振幅分别为11.75%、10.39%、9.50%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422321796394489&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422321796394489&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4548","BK4139","BK4609","RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516630506","title":"Recursion Pharmaceuticals, Inc.盘中异动 快速跳水5.06%报7.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516630506","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516630506?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:14","pubTimestamp":1741014893,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时14分，Recursion Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.06%。截至发稿，该股报7.13美元/股，成交量584.537万股，换手率1.45%，振幅9.99%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1588.23%、132.29%、107.64%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为177.97%、70.53%、48.34%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032314549637b807&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032314549637b807&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4609","BK4139","RXRX","BK4548"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2516022813","title":"Leerink Partners：维持Recursion Pharmaceuticals(RXRX.US)评级，由大市一致调整至大市一致评级, 目标价由7.00美元调整至6.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516022813","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516022813?lang=zh_cn&edition=full","pubTime":"2025-03-01 05:47","pubTimestamp":1740779249,"startTime":"0","endTime":"0","summary":"Leerink Partners：维持Recursion Pharmaceuticals(RXRX.US)评级，由大市一致调整至大市一致评级, 目标价由7.00美元调整至6.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01054748470353.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108509860","title":"盘前｜英伟达持仓股齐跌，RXRX跌超12%；今晚美联储“首选通胀指标”来袭","url":"https://stock-news.laohu8.com/highlight/detail?id=1108509860","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108509860?lang=zh_cn&edition=full","pubTime":"2025-02-28 20:44","pubTimestamp":1740746647,"startTime":"0","endTime":"0","summary":"报告充斥着诸多不实之词$英伟达$盘前由涨转跌，其持仓概念股纷纷下挫，RXRX跌超12%明星中概股普跌，$小鹏汽车$跌超7%财报股表现：SoundHound AI涨超3%，$戴尔$跌近4%，RKLB跌超15%2月28日，美股三大股指期货上涨，截止发稿，道指期货涨0.37%，纳指期货涨0.06%，标普500指数期货涨0.24%。盘前行情英伟达盘前由涨转跌，其持仓概念股纷纷下挫，Recursion Pharmaceuticals跌超12%，$NEBIUS$跌超4%，Applied Digital跌近4%，$文远知行$跌超2%。","market":"us","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4587","BK1119","BK4588","RXRX","IE00BHPRN162.USD","IE0004091025.USD","BK4555","BK4533","BK4550","NVDA","IE0004086264.USD","IE00BJJMRX11.SGD","BK1539","IE0009356076.USD","RKLB","BK4579","GB00BDT5M118.USD","IE00BKVL7J92.USD","XPEV"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1127500860","title":"Recursion Pharmaceuticals盘前跌超11%，Q4营收不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1127500860","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127500860?lang=zh_cn&edition=full","pubTime":"2025-02-28 20:09","pubTimestamp":1740744598,"startTime":"0","endTime":"0","summary":"2月28日，Recursion Pharmaceuticals盘前跌超11%，财报显示：2024年第四季度营业收入为451.1万美元，不及市场预期，去年同期1062.4万美元。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Recursion Pharmaceuticals盘前跌超11%，Q4营收不及预期","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","BK4548","RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105563112","title":"异动解读 | RXRX盘前大跌5.87%,业绩低于预期或是主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1105563112","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105563112?lang=zh_cn&edition=full","pubTime":"2025-02-28 19:40","pubTimestamp":1740742851,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals(纳斯达克:RXRX)于周五盘前大跌5.87%,引发了市场广泛关注。\n公司近期公布的2022年第四季度财报显示,每股亏损0.53美元,远超分析师预期的0.46美元亏损。营收方面,RXRX季度销售额仅为455万美元,大幅低于市场预期的1904万美元。\n这一业绩低于预期的情况可能是导致盘前股价大跌的主要原因。不过,目前尚未有其他公开信息可以解释这一跌幅。投资者或需进一步关注公司未来发展,以判断是否存在更深层次的影响因素。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137020833","title":"Recursion Pharmaceuticals 第四季度每股收益 $(0.53) 不及预期 $(0.46)，销售额 $4.55M 低于预期 $19.04M","url":"https://stock-news.laohu8.com/highlight/detail?id=1137020833","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137020833?lang=zh_cn&edition=full","pubTime":"2025-02-28 19:36","pubTimestamp":1740742604,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals报告季度每股亏损 $，与分析师共识预期的 $ 相比，低了15.22%。与去年同期每股亏损 $ 相比下降了26.19%。以上内容来自Benzinga Earnings专栏，原文如下：Recursion Pharmaceuticals  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 15.22 percent. This is a 26.19 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $4.55 million which missed the analyst consensus estimate of $19.04 million by 76.13 percent.  This is a 58.26 percen","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Recursion Pharmaceuticals 第四季度每股收益 $(0.53) 不及预期 $(0.46)，销售额 $4.55M 低于预期 $19.04M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2514867334","title":"Recursion Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514867334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514867334?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:32","pubTimestamp":1740684731,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时32分，Recursion Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.04%。截至发稿，该股报7.92美元/股，成交量1706.36万股，换手率4.37%，振幅7.67%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Heron Therapeutics, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1902.95%、330.28%、183.35%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280332129632e84e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280332129632e84e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RXRX","BK4539","BK4139","BK4548","BK4609"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2514851810","title":"Recursion Pharmaceuticals, Inc.盘中异动 早盘急速上涨6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514851810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514851810?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:32","pubTimestamp":1740580325,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时32分，Recursion Pharmaceuticals, Inc.股票出现波动，股价大幅上涨6.08%。截至发稿，该股报8.64美元/股，成交量224.996万股，换手率0.58%，振幅1.97%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Enveric Biosciences, Inc.、Nutriband Inc C/Wts 、Channel Therapeutics Corporation涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为2782.30%、115.75%、90.27%，振幅较大的相关个股有Enveric Biosciences, Inc.、Channel Therapeutics Corporation、Cns Pharmaceuticals, Inc.，振幅分别为28.81%、16.85%、14.35%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223205abddecd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223205abddecd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RXRX","BK4539","BK4609","BK4139","BK4548"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2514090413","title":"Recursion Pharmaceuticals, Inc.盘中异动 大幅下跌5.44%报8.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514090413?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:31","pubTimestamp":1740493861,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时31分，Recursion Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.44%。截至发稿，该股报8.51美元/股，成交量147.616万股，换手率0.38%，振幅0.23%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Organovo Holdings, Inc.、Moleculin Biotech, Inc.、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为746.06%、508.58%、459.43%，振幅较大的相关个股有Organovo Holdings, Inc.、Igm Biosciences, Inc.、Bicara Therapeutics Inc.，振幅分别为8.10%、7.46%、5.62%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223101a253864d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223101a253864d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4609","BK4548","BK4139","RXRX","BK4539"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.recursion.com;ir.recursion.com","stockEarnings":[{"period":"1week","weight":-0.1717},{"period":"1month","weight":0.1984},{"period":"3month","weight":0.1586},{"period":"6month","weight":0.0653},{"period":"1year","weight":-0.3065},{"period":"ytd","weight":-0.0623}],"compareEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":0.018},{"period":"3month","weight":0.0307},{"period":"6month","weight":0.1088},{"period":"1year","weight":0.1734},{"period":"ytd","weight":0.1409}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Recursion Pharmaceuticals, Inc.最初成立于2013年11月4日，并在特拉华州注册成立 。 该公司是一家领先的临床阶段TechBio公司，将生物解码以将药物发现产业化。公司使命的核心是递归操作系统（OS），这是一个跨多种技术构建的平台，使公司能够在超过50 PB的专有数据中绘制和导航数万亿个以生物、化学和患者为中心的关系。该公司将物理和数字组件的这种集成框定为迭代循环，其中规模化的“湿实验室”生物学、化学和以患者为中心的实验数据由“干实验室”计算工具组织，以便识别、验证和翻译治疗见解。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.035717},{"month":2,"riseRate":0.4,"avgChangeRate":0.049361},{"month":3,"riseRate":0,"avgChangeRate":-0.249219},{"month":4,"riseRate":0.4,"avgChangeRate":-0.090167},{"month":5,"riseRate":0.5,"avgChangeRate":0.076509},{"month":6,"riseRate":0.666667,"avgChangeRate":0.117519},{"month":7,"riseRate":0.666667,"avgChangeRate":0.141285},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.083252},{"month":9,"riseRate":0.5,"avgChangeRate":-0.006288},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.077878},{"month":11,"riseRate":0.4,"avgChangeRate":0.028843},{"month":12,"riseRate":0.2,"avgChangeRate":-0.000986}],"exchange":"NASDAQ","name":"Recursion Pharmaceuticals, Inc.","nameEN":"Recursion Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Recursion Pharmaceuticals, Inc.(RXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Recursion Pharmaceuticals, Inc.(RXRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Recursion Pharmaceuticals, Inc.,RXRX,Recursion Pharmaceuticals, Inc.股票,Recursion Pharmaceuticals, Inc.股票老虎,Recursion Pharmaceuticals, Inc.股票老虎国际,Recursion Pharmaceuticals, Inc.行情,Recursion Pharmaceuticals, Inc.股票行情,Recursion Pharmaceuticals, Inc.股价,Recursion Pharmaceuticals, Inc.股市,Recursion Pharmaceuticals, Inc.股票价格,Recursion Pharmaceuticals, Inc.股票交易,Recursion Pharmaceuticals, Inc.股票购买,Recursion Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Recursion Pharmaceuticals, Inc.(RXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Recursion Pharmaceuticals, Inc.(RXRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}